Accelerating Life Science innovation through real-world data
We run complete Real-World Evidence studies, from protocol design to scientific publication. Our healthcare, data science and engineering expertise sets us apart in the Latin American market.
Present in every phase of the Life Science industry
From clinical development to post-marketing: disease characterization, market sizing, evidence for access and reimbursement, pharmacovigilance and real-life outcomes.
Three study formats, one quality standard
Template-Based RWE Solution
Concise protocols to characterize diseases, treatments, costs and usage patterns — delivering insights on incidence, prevalence, patient journey and other relevant indicators, fast.
Tailored RWE Solution
More complex studies with new protocols and, often, data enrichment with data science algorithms — lines of therapy, linkage, phenotypes. Inferential studies usually fit here.
Routine Repeated Analyses
Recurring analyses delivered as periodic reports — such as value-based healthcare (VBHC) contract audits with monthly clinical indicators through a secure federated provider data flow.
Precision Evidence methodology: auditable, reproducible and federated
Every study follows 8 steps with clear responsibilities between Precision Data and Data Partners — from protocol to CSR — on a federated infrastructure where no individual-level data leaves the source.
- Public (DATASUS, ANS) and private (Data Partner) databases from Brazil, Mexico, Colombia and Chile
- OMOP CDM standard and OHDSI tools for international comparability
- Team with 100+ published papers and an OHDSI Global Symposium award
Shall we design your next study?
Tell us the research question, the population and the market. We come back with design, databases and timeline.